Received May 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
The patient felt badly; This non-serious case was reported by a physician via sales rep and described the occurrence of feeling abnormal in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced feeling abnormal (Verbatim: The patient felt badly). The outcome of the feeling abnormal was not reported. It was unknown if the reporter considered the feeling abnormal to be related to Shingrix. It was unknown if the company considered the feeling abnormal to be related to Shingrix. Additional Information: GSK Receipt Date: 20-MAY-2025 The patient felt badly after dose 1 of Shingrix. The patient refused to take dose 2 of Shingrix due to the side effects of dose 1.